These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449 [TBL] [Abstract][Full Text] [Related]
46. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids. Rozenberg S; Ylikorkala O; Arrenbrecht S Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385 [TBL] [Abstract][Full Text] [Related]
47. [Efficacy of combined oral hormone replacement therapy in postmenopausal symptoms]. Szántó F; Hörömpöli C Orv Hetil; 1996 May; 137(20):1079-81. PubMed ID: 8657419 [TBL] [Abstract][Full Text] [Related]
48. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Josse RG CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542 [TBL] [Abstract][Full Text] [Related]
49. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women. Archer DF Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205 [TBL] [Abstract][Full Text] [Related]
50. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]